To request a free sample copy of this report, please complete the form below.
What people say about us!

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

logos logos logos logos logos
Analyst Support
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.



Pain Management Devices Market size was valued at around USD 7.0 billion in 2022 and is expected to rise from USD 7.65 billion in 2023 to reach a value of USD 15.58 billion by 2031, at a CAGR of 9.3% over the forecast period (2024–2031).

To increase their market penetration, key vendors are continually engaged in strategic efforts such as technology innovation, partnerships, geographical expansion, and mergers and acquisitions. For instance, Medtronic announced the commercial introduction of the InterStim Micro Neurostimulator, a neurostimulator that has received FDA approval, in August 2020. The device was designed to aid patients in regaining reliable bladder and bowel control through sacral neuromodulation (SNM) therapy. 'Abbott Laboratories', 'Medtronic', 'Boston Scientific', 'Pfizer', 'Johnson & Johnson', 'Nevro Corporation', 'Baxter International', 'St. Jude Medical', 'B. Braun Melsungen AG', 'Smiths Medical', 'Hospira', 'Endo International', 'Djo Global', 'Halyard Health', 'Stryker Corporation', 'NeuroMetrix', 'Avanos Medical', 'NIPRO Corporation', 'Terumo Corporation', 'Stimwave Technologies'

The rising prevalence of chronic pain conditions, such as arthritis, cancer, and back pain, is one of the major drivers of the pain management device market. With a rising population affected by various chronic pain conditions such as arthritis, lower back pain, and neuropathic pain, there is a growing demand for advanced pain management solutions. These devices offer non-invasive or minimally invasive alternatives to traditional pain management methods, providing patients with improved comfort and quality of life. As a result, there is significant growth in the pain management device market, driven by both healthcare professionals and patients searching for novel and efficient solutions to relieve chronic pain while decreasing their dependency on pharmaceutical treatments.

Increasing Demand for Non-Invasive Pain Management: Patients are increasingly seeking non-invasive pain management options, such as transcutaneous electrical nerve stimulation (TENS) devices and wearable pain management devices. These types of devices are becoming more widely available and are gaining popularity due to their ease of use and ability to provide targeted pain relief without the need for surgery or medication.

North America held a revenue share of over 46.00% because of the region's favorable healthcare infrastructure, which makes it simple to obtain state-of-the-art pain management equipment. A rise in government initiatives like the Affordable Care Act and Precision Medicine, as well as a carefully planned reimbursement system in this field, are also contributing to the market's progress. The regional market is also being driven by an aging population, well-established healthcare facilities, and a high prevalence of hypertension and stroke. The market is expected to expand more swiftly as the elderly population increases since an aging population is more likely to have chronic illnesses.

Feedback From Our Clients

Global Pain Management Devices Market

Product ID: SQMIG35A2502